Ovarian cancer

Jo Ann H. Eriksson, Janet Ruth Walczak

Research output: Contribution to journalArticle

Abstract

Prevention, early detection, morbidity, and survival issues continue to challenge health professionals involved in the care of women with ovarian cancer. While advances in diagnosis, staging, and treatment have been made, survival rates remain grim. Continuing research in the areas of screening, diagnosis, and treatment is the key to improved survival. The hope of new drug therapy, such as cisplatin-taxol regimens, intraperitoneal therapy, immunotherapy, and bone marrow transplantation, needs further investigation to become reality. As new and potentially more toxic regimens are developed, the nurse must be knowledgeable about the therapies and adverse effects, and maintain a high level of clinical expertise in order to teach the patient, reinforce information, clarify misconceptions, and provide the patient with supportive physical and emotional care.

Original languageEnglish (US)
Pages (from-to)214-227
Number of pages14
JournalSeminars in oncology nursing
Volume6
Issue number3
DOIs
StatePublished - Aug 1990

ASJC Scopus subject areas

  • Oncology(nursing)

Fingerprint Dive into the research topics of 'Ovarian cancer'. Together they form a unique fingerprint.

  • Cite this

    Eriksson, J. A. H., & Walczak, J. R. (1990). Ovarian cancer. Seminars in oncology nursing, 6(3), 214-227. https://doi.org/10.1016/0749-2081(90)90006-Q